Bowel Cancer: Medical Treatments
Commons · Question 127075 · Tabled 14 Apr 2026 · Department of Health and Social Care · Official record
Answered 21 Apr 2026
Question
Asked by Mary Glindon
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of access to treatment for patients with BRAF-mutated bowel cancer in (a) England and (b) Northern Ireland.
Answer
Answered by Zubir Ahmed, 21 Apr 2026
The National Health Service in England is legally required to fund medicines in line with National Institute for Health and Care Excellence’s (NICE) recommendations. Current treatment options for BRAF-mutated colorectal cancer depend on the stage of the d...